Proton Therapy Equipment and Services
Search documents
IBA – Regulated information
Globenewswire· 2025-11-07 17:00
Company Overview - IBA (Ion Beam Applications S.A.) is a global leader in particle accelerator technology, specializing in proton therapy, industrial sterilization, radiopharmaceuticals, and dosimetry [5][6] - The company is headquartered in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people worldwide [5] - IBA is recognized as a certified B Corporation (B Corp), meeting high standards of verified social and environmental performance [5] Financial Information - The total capital of IBA is reported at EUR 42,502,318.54 [2] - The number of securities with voting rights is 30,282,218, which is the basis for calculating the 30% threshold under the takeover law [2] - The existing voting rights total 40,514,619, which serves as the denominator for calculating the quota of voting rights that may trigger notification requirements [2] Voting Rights and Regulations - IBA has introduced loyalty voting rights, which apply to registered shares held for at least two consecutive years [3] - The calculation method for loyalty voting rights is based on the LIFO (last in, first out) method [4] - There is a statutory ceiling that limits any shareholder's voting participation to a maximum of 35% of the total votes attached to shares with voting rights, equating to approximately 14,180,116.65 votes based on current figures [5]